1
|
Marchand WR, Lee JN, Suchy Y, et al:
Age-related changes of the functional architecture of the
cortico-basal ganglia circuitry during motor task execution.
Neuroimage. 55:194–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Goldsmith TC: Mammal aging: Active and
passive mechanisms and their medical implications. Biosci
Hypotheses. 2:59–64. 2009. View Article : Google Scholar
|
3
|
Alichniewicz KK, Brunner F, Klünemann HH
and Greenlee MW: Structural and functional neural correlates of
visuospatial information processing in normal aging and amnestic
mild cognitive impairment. Neurobiol Aging. 33:2782–2797. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Fowler MR, Naz JR, Graham MD, Orchard CH
and Harrison SM: Age and hypertrophy alter the contribution of
sarcoplasmic reticulum and Na+/Ca2+ exchange
to Ca2+ removal in rat left ventricular myocytes. J Mol
Cell Cardiol. 42:582–589. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Steppan J, Tran H, Benjo AM, et al:
Alagebrium in combination with exercise ameliorates age-associated
ventricular and vascular stiffness. Exp Gerontol. 47:565–572. 2012.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Hung CL, Wu YJ, Liu CC, et al: Age-related
ventricular remodeling is an independent risk for heart failure
symptoms in subjects with preserved systolic function. Int J
Gerontol. 5:17–24. 2011. View Article : Google Scholar
|
7
|
Fraysse B, Weinberger F, Bardswell SC, et
al: Increased myofilament Ca2+ sensitivity and diastolic
dysfunction as early consequences of Mybpc3 mutation in
heterozygous knock-in mice. J Mol Cell Cardiol. 52:1299–1307.
2012.
|
8
|
Chatterjee K: Pathophysiology of systolic
and diastolic heart failure. Med Clin North Am. 96:891–899. 2012.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Strait JB and Lakatta EG: Cardiac aging:
From humans to molecules. Muscle 2-Volume Set: Fundamental Biology
and Mechanisms of Disease. Hill JA and Olson EN: 1st edition.
Academic Press; Waltham, MA: pp. 639–659. 2012, View Article : Google Scholar
|
10
|
Boyle AJ, Shih H, Hwang J, et al:
Cardiomyopathy of aging in the mammalian heart is characterized by
myocardial hypertrophy, fibrosis and a predisposition towards
cardiomyocyte apoptosis and autophagy. Exp Gerontol. 46:549–559.
2011. View Article : Google Scholar
|
11
|
Gonzalez-Aparicio R, Flores JA, Tasset I,
Tunez I and Fernandez-Espejo E: Mice lacking the peroxisome
proliferator-activated receptor alpha gene present reduced number
of dopamine neurons in the substantia nigra without altering motor
behavior or dopamine neuron decline over life. Neuroscience.
186:161–169. 2011. View Article : Google Scholar
|
12
|
Wang XJ, Zhang S, Yan ZQ, et al: Impaired
CD200-CD200R-mediated microglia silencing enhances midbrain
dopaminergic neurodegeneration: roles of aging, superoxide, NADPH
oxidase, and p38 MAPK. Free Radic Biol Med. 50:1094–1106. 2011.
View Article : Google Scholar
|
13
|
Pisciotta L, Sallo R, Rabacchi C, Wunsch
A, Calandra S and Bertolini S: Leucine 10 allelic variant in signal
peptide of PCSK9 increases the LDL cholesterol-lowering effect of
statins in patients with familial hypercholesterolaemia. Nutr Metab
Cardiovasc Dis. 22:831–835. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Owens CD: Statins and other agents for
vascular inflammation. J Vasc Surg. 56:1799–1806. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Obregón O, Gestne A, Lares M, et al:
Efectos tempranos de las estatinas: inflamación y oxidación. Clin
Invest Arterioscl. 23:269–274. 2011.(In Spanish).
|
16
|
Marrone G, Russo L, Rosado E, et al: The
transcription factor KLF2 mediates hepatic endothelial protection
and paracrine endothelial-stellate cell deactivation induced by
statins. J Hepatol. 58:98–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yokomizo A, Shiota M, Kashiwagi E, et al:
Statins reduce the androgen sensitivity and cell proliferation by
decreasing the androgen receptor protein in prostate cancer cells.
Prostate. 71:298–304. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Shin SK, Lee YK, Jo YI and Chang TI: The
effects of statins unrelated to cholesterol level on clinical
outcome of continuous ambulatory peritoneal dialysis patients.
Kidney Research and Clinical Practice. 31:A732012. View Article : Google Scholar
|
19
|
Choi EY, Chang W, Lim S, et al:
Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy
via suppression of Gh. Eur J Pharmacol. 627:56–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Sverdrup FM, Yates MP, Vickery LE, et al:
Protein geranylgeranylation controls collagenase expression in
osteoarthritic cartilage. Osteoarthritis Cartilage. 18:948–955.
2010. View Article : Google Scholar
|
21
|
Murrow JR, Sher S, Ali S, et al: The
differential effect of statins on oxidative stress and endothelial
function: atorvastatin versus pravastatin. J Clin Lipidol. 6:42–49.
2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chuang YH, Chuang WL, Huang SP, Liu CK and
Huang CH: Atorvastatin ameliorates tissue damage of obstructed
ureter in rats. Life Sci. 89:795–805. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yang P, Li Y, Li JJ, Qin L and Li XY:
Up-regulating PPAR-gamma expression and NO concentration, and
down-regulating PAI-1 concentration in a rabbit atherosclerotic
model: the possible antiatherogenic and antithrombotic effects of
atorvastatin. Int J Cardiol. 139:213–217. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Garjani A, Andalib S, Biabani S, Soraya H,
Doustar Y, Garjani A and Maleki-Dizaji N: Combined atorvastatin and
coenzyme Q10 improve the left ventricular function in
isoproterenol-induced heart failure in rat. Eur J Pharmacol.
666:135–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Koh KK, Quon MJ, Han SH, et al: Additive
beneficial effects of atorvastatin combined with amlodipine in
patients with mild-to-moderate hypertension. Int J Cardiol.
146:319–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
26
|
Han L, Li M, Liu Y, Han C and Ye P:
Atorvastatin may delay cardiac aging by upregulating peroxisome
proliferator-activated receptors in rats. Pharmacology. 89:74–82.
2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kobayashi M, Chisaki I, Narumi K, et al:
Association between risk of myopathy and cholesterol-lowering
effect: a comparison of all statins. Life Sci. 82:969–975. 2008.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Doyon M, Hale TM, Huot-Marchand JE, Wu R,
de Champlain J and deBlois D: Does atorvastatin induce aortic
smooth muscle cell apoptosis in vivo? Vascular Pharmacol. 54:5–12.
2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Asakawa M, Takano H, Nagai T, Uozumi H,
Hasegawa H, Kubota N, Saito T, Masuda Y, Kadowaki T and Komuro I:
Peroxisome proliferator-activated receptor gamma plays a critical
role in inhibition of cardiac hypertrophy in vitro and in
vivo. Circulation. 105:1240–1246. 2002. View Article : Google Scholar
|
30
|
Hsu S, Nagayama T, Koitabashi N, et al:
Phosphodiesterase 5 inhibition blocks-pressure overload-induced
cardiac hypertrophy independent of the calcineurin pathway.
Cardiovasc Res. 81:301–309. 2009. View Article : Google Scholar
|
31
|
Bao XM, Wu CF and Lu GP: Atorvastatin
inhibits homocysteine-induced oxidative stress and apoptosis in
endothelial progenitor cells involving Nox4 and p38MAPK.
Atherosclerosis. 210:114–121. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yu X and Li G: Effects of resveratrol on
longevity, cognitive ability and aging-related histological markers
in the annual fish Nothobranchius guentheri. Exp Gerontol.
47:940–949. 2012. View Article : Google Scholar : PubMed/NCBI
|
33
|
Höhn A, Sittig A, Jung T, Grimm S and
Grune T: Lipofuscin is formed independently of macroautophagy and
lysosomal activity in stress-induced prematurely senescent human
fibroblasts. Free Radic Biol Med. 53:1760–1769. 2012.PubMed/NCBI
|